These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 8335820

  • 1. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene.
    Solomon SD, Wolff S, Watkins H, Ridker PM, Come P, McKenna WJ, Seidman CE, Lee RT.
    J Am Coll Cardiol; 1993 Aug; 22(2):498-505. PubMed ID: 8335820
    [Abstract] [Full Text] [Related]

  • 2. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.
    Posen BM, Moolman JC, Corfield VA, Brink PA.
    Br Heart J; 1995 Jul; 74(1):40-6. PubMed ID: 7662452
    [Abstract] [Full Text] [Related]

  • 3. Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy.
    Hagège AA, Dubourg O, Desnos M, Mirochnik R, Isnard G, Bonne G, Carrier L, Guicheney P, Bouhour JB, Schwartz K, Komajda M.
    Eur Heart J; 1998 Mar; 19(3):490-9. PubMed ID: 9568454
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients.
    Klues HG, Schiffers A, Maron BJ.
    J Am Coll Cardiol; 1995 Dec; 26(7):1699-708. PubMed ID: 7594106
    [Abstract] [Full Text] [Related]

  • 5. Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy.
    Jouven X, Hagege A, Charron P, Carrier L, Dubourg O, Langlard JM, Aliaga S, Bouhour JB, Schwartz K, Desnos M, Komajda M.
    Heart; 2002 Aug; 88(2):153-7. PubMed ID: 12117842
    [Abstract] [Full Text] [Related]

  • 6. Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation.
    Chelliah RK, Senior R.
    Future Cardiol; 2009 Sep; 5(5):495-502. PubMed ID: 19715413
    [Abstract] [Full Text] [Related]

  • 7. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes.
    Rosenzweig A, Watkins H, Hwang DS, Miri M, McKenna W, Traill TA, Seidman JG, Seidman CE.
    N Engl J Med; 1991 Dec 19; 325(25):1753-60. PubMed ID: 1944483
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.
    Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, Seidman CE.
    J Am Coll Cardiol; 2001 Aug 19; 38(2):315-21. PubMed ID: 11499718
    [Abstract] [Full Text] [Related]

  • 11. Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy.
    Brown ML, Schaff HV, Dearani JA, Li Z, Nishimura RA, Ommen SR.
    J Thorac Cardiovasc Surg; 2011 Feb 19; 141(2):439-43. PubMed ID: 20832083
    [Abstract] [Full Text] [Related]

  • 12. [Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical ASH)].
    Koga Y, Takahashi H, Ifuku M, Itaya M, Adachi K, Toshima H.
    J Cardiogr; 1984 Aug 19; 14(2):301-10. PubMed ID: 6543446
    [Abstract] [Full Text] [Related]

  • 13. QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy.
    Sakata K, Shimizu M, Ino H, Yamaguchi M, Terai H, Hayashi K, Kiyama M, Hayashi T, Inoue M, Mabuchi H.
    Heart; 2003 Aug 19; 89(8):882-6. PubMed ID: 12860864
    [Abstract] [Full Text] [Related]

  • 14. Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy.
    Klues HG, Roberts WC, Maron BJ.
    Circulation; 1993 May 19; 87(5):1570-9. PubMed ID: 8491013
    [Abstract] [Full Text] [Related]

  • 15. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life.
    Lewis JF, Maron BJ.
    J Am Coll Cardiol; 1989 Jan 19; 13(1):36-45. PubMed ID: 2909578
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
    Blauwet LA, Ackerman MJ, Edwards WD, Riehle DL, Ommen SR.
    Cardiovasc Pathol; 2009 Jan 19; 18(5):262-8. PubMed ID: 18835191
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Echocardiographic assessment of left ventricular hypertrophy in patients with obstructive or nonobstructive hypertrophic cardiomyopathy.
    Maron BJ.
    Eur Heart J; 1983 Nov 19; 4 Suppl F():73-91. PubMed ID: 6686547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.